Featured Research

from universities, journals, and other organizations

Novel Anti-inflammatory Molecules Of Microbial Origin

Date:
September 8, 2009
Source:
CNRS (Délégation Paris Michel-Ange)
Summary:
By studying the mycobacteria that cause tuberculosis, molecules with anti-inflammatory properties have been identified by researchers. These molecules, as well as several new analogs, have now been synthesized. In a new study, researchers report the anti-inflammatory activity of these molecules.

By studying the mycobacteria that cause tuberculosis, molecules with anti-inflammatory properties have been identified by the team led by Valérie Quesniaux in the Laboratoire Immunologie et Embryologie Moléculaires, working in collaboration with the Institut de Chimie Organique et Analytique (both based in the University of Orléans/CNRS). These molecules, as well as several new analogs, have been synthesized. Their anti-inflammatory activity has been confirmed, improved and demonstrated in the mouse, as reported in The Journal of Biological Chemistry on August 28, 2009.

The mycobacteria that cause tuberculosis (Mycobacterium tuberculosis) can remain silent for many years in man, thus eluding surveillance by the immune system. In 90% of individuals, the infection is controlled but not eradicated, and the mycobacterium can sometimes survive for several decades. Mycobacterium tuberculosis produces several complex proteins and glycolipids (a combination of sugars and lipids) that are capable of modulating the immune response.

Valérie Quesniaux's team has focused on the interactions between the mycobacterium and its host at the molecular scale, and on the resulting immune mechanisms. On the cell wall of the mycobacteria, the scientists identified low molecular mass glycolipids with very interesting anti-inflammatory properties, the PIM (Phosphatidyl Inositol Mannosides). They synthesized these PIM and reproduced their anti-inflammatory properties.

The team then turned to the synthesis of novel, analog molecules, thus considerably simplifying their synthesis. And indeed, the first example of this new family proved to be even more active than the natural or synthetic molecules tested hitherto. During their study, the researchers demonstrated the enhanced anti-inflammatory activity of these novel PIM molecules both in vitro and in an in vivo model of pulmonary inflammation.

Two patents have been filed in the context of this research. The use of such immunomodulating molecules of microbial origin for therapeutic purposes is seeing considerable growth. These new molecules could be used in the treatment of severe, chronic, inflammatory diseases such as rheumatoid arthritis, Crohn's disease or psoriasis.


Story Source:

The above story is based on materials provided by CNRS (Délégation Paris Michel-Ange). Note: Materials may be edited for content and length.


Journal Reference:

  1. Emilie Doz, Stéphanie Rose, Nathalie Court, Sophie Front, Virginie Vasseur, Sabine Charron, Martine Gilleron, Germain Puzo, Isabelle Fremaux, Yves Delneste, François Erard, Bernhard Ryffel, Olivier R. Martin and Valerie F. J. Quesniaux. Mycobacterial Phosphatidylinositol Mannosides Negatively Regulate Host Toll-like Receptor 4, MyD88-dependent Proinflammatory Cytokines, and TRIF-dependent Co-stimulatory Molecule Expression. Journal of Biological Chemistry, 2009; 284 (35): 23187 DOI: 10.1074/jbc.M109.037846

Cite This Page:

CNRS (Délégation Paris Michel-Ange). "Novel Anti-inflammatory Molecules Of Microbial Origin." ScienceDaily. ScienceDaily, 8 September 2009. <www.sciencedaily.com/releases/2009/09/090902122525.htm>.
CNRS (Délégation Paris Michel-Ange). (2009, September 8). Novel Anti-inflammatory Molecules Of Microbial Origin. ScienceDaily. Retrieved August 28, 2014 from www.sciencedaily.com/releases/2009/09/090902122525.htm
CNRS (Délégation Paris Michel-Ange). "Novel Anti-inflammatory Molecules Of Microbial Origin." ScienceDaily. www.sciencedaily.com/releases/2009/09/090902122525.htm (accessed August 28, 2014).

Share This




More Health & Medicine News

Thursday, August 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mini Pacemaker Has No Wires

Mini Pacemaker Has No Wires

Ivanhoe (Aug. 27, 2014) — Cardiac experts are testing a new experimental device designed to eliminate major surgery and still keep the heart on track. Video provided by Ivanhoe
Powered by NewsLook.com
After Cancer: Rebuilding Breasts With Fat

After Cancer: Rebuilding Breasts With Fat

Ivanhoe (Aug. 27, 2014) — More than 269 million women are diagnosed with breast cancer each year. Many of them will need surgery and radiation, but there’s a new simple way to reconstruct tissue using a patient’s own fat. Video provided by Ivanhoe
Powered by NewsLook.com
Blood Clots in Kids

Blood Clots in Kids

Ivanhoe (Aug. 27, 2014) — Every year, up to 200,000 Americans die from a blood clot that travels to their lungs. You’ve heard about clots in adults, but new research shows kids can get them too. Video provided by Ivanhoe
Powered by NewsLook.com
Radio Waves Knock out Knee Pain

Radio Waves Knock out Knee Pain

Ivanhoe (Aug. 27, 2014) — Doctors have used radio frequency ablation or RFA to reduce neck and back pain for years. But now, that same technique is providing longer-term relief for patients with severe knee pain. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins